Shirin A Ahmed

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Sana is a digital health company driven by 25 years of research. The innovative audiovisual technology allows you to accelerate your physical recovery and improve your mental well-being, offering a more restful state of mind. The Sana device is not currently approved by the FDA for any medical condition and should be used for the purposes of rest and recovery only, until such time as appropriate clinical evidence is approved through FDA processes.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Sana is a digital health company driven by 25 years of research. The innovative audiovisual technology allows you to accelerate your physical recovery and improve your mental well-being, offering a more restful state of mind. The Sana device is not currently approved by the FDA for any medical condition and should be used for the purposes of rest and recovery only, until such time as appropriate clinical evidence is approved through FDA processes.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.

MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate. DISRUPTING TO ADVANCE HEALTHCARE MobileODT is blazing a path similar to disruptive technologies in other markets: We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability. We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes. And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs. ​FIRST FOCUS: CERVICAL CANCER SCREENING MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech